| Literature DB >> 28422083 |
Tiglu Gebre1, Mulualem Tadesse2,3, Dossegnaw Aragaw4,5, Dagne Feye6, Habtamu Bedimo Beyene7, Dinberu Seyoum8, Mekidim Mekonnen9.
Abstract
Nasopharyngeal carriage of Streptococcus pneumoniae is found to play an important role in the development and transmission of pneumococcal diseases. In this study, we assessed the nasopharyngeal carriage, antimicrobial susceptibility patterns and associated risk factors of S. pneumoniae among children under five. A total of 361 children under five attending the outpatient department of Shanan Gibe Hospital in Jimma, Southwest Ethiopia were enrolled from June to September 2014. Nasopharyngeal specimens were collected using sterile plastic applicator rayon tipped swab and inoculated on tryptone soy agar supplemented with 5% sheep blood and 5 µg/mL gentamycin. Antimicrobial susceptibility testing was performed using the modified disk diffusion method. The overall prevalence of S. pneumoniae carriage was 43.8% (158/361) among children under five. Resistance to tetracycline, cotrimoxazole, penicillin, chloramphenicol and erythromycin was observed in 53.2% (84/158), 43.7% (69/158), 36.1% (57/158), 13.3% (21/158) and 8.9% (14/158) of isolates respectively. Multidrug resistance was seen in 17.7% (28/158) of isolates. In multivariate logistic regression analysis, children living with sibling(s) < 5 years old (adjusted odds ratio (AOR) = 1.798; 95% confidence interval (CI), 1.169-2.766) and malnutrition (AOR = 2.065; 95% CI, 1.239-3.443) were significantly associated with S. pneumoniae carriage. A high nasopharyngeal carriage of S. pneumoniae was observed among children under five in Southwest Ethiopia. There should be a strategy to prevent S. pneumoniae nasopharyngeal colonization and identify the appropriate antibiotic to the individual child.Entities:
Keywords: Streptococcus pneumoniae; antimicrobial susceptibility; nasopharyngeal carriage; risk factor
Year: 2017 PMID: 28422083 PMCID: PMC5406686 DOI: 10.3390/children4040027
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067
Socio-demographic and clinical characteristics of children under five included in this study (n = 361).
| Characteristics Study Participants | ||
|---|---|---|
| Sex | Male | 206 (57.1) |
| Female | 155 (42.9) | |
| Age in months | 2–23 | 192 (53.2) |
| 24–41 | 93 (25.8) | |
| 42–59 | 76 (21.0) | |
| Place of residence | Urban | 284 (78.7) |
| Rural | 77 (21.3) | |
| Attending kindergarten/school | Yes | 16 (4.4) |
| No | 345 (95.6) | |
| Family size | <5 | 189 (52.4) |
| ≥5 | 172 (47.6) | |
| Having sibling(s) (at least 1) in house | Yes | 258 (71.5) |
| No | 103 (28.5) | |
| Age of sibling(s) < 5 years | Yes | 164 (45.4) |
| No | 197 (54.6) | |
| Age of sibling(s) ≥ 5 years | Yes | 194 (53.7) |
| No | 168 (46.3) | |
| Bed sharing with parent/guardian | Yes | 294 (81.4) |
| No | 67 (18.6) | |
| Number of room(s) in the house | 1 | 90 (24.9) |
| ≥2 | 271 (75.1) | |
| PCV immunization status | Fully vaccinated * | 249 (69) |
| Partially vaccinated ** | 25 (6.9) | |
| None vaccinated | 87 (24.1) | |
| Pneumonia | Yes | 79 (21.9) |
| No | 282 (78.1) | |
| Otitis media | Yes | 12 (3.3) |
| No | 349 (96.7) | |
| Sinusitis | Yes | 19 (5.3) |
| No | 342 (94.7) | |
* vaccinated with 3 doses of pneumococcal conjugate vaccine (PCV); ** vaccinated with 1 or 2 doses of PCV.
Antimicrobial susceptibility patterns of Streptococcus pneumoniae isolates (n = 158).
| Antimicrobial Agents | Susceptibility Pattern | ||
|---|---|---|---|
| Resistant | Intermediate | Susceptible | |
| Tetracycline | 69 (43.7) | 15 (9.5) | 74 (46.8) |
| TMP-SMX | 60 (38.0) | 9 (5.7) | 89 (56.3) |
| Penicillin | 57 (36.1) | 0 (0) | 101 (63.9) |
| Chloramphenicol | 21 (13.3) | 0 (0) | 137 (86.7) |
| Erythromycin | 9 (5.7) | 5 (3.2) | 144 (91.1) |
TMP-SMX: Trimethoprim-sulfamethoxazole.
Univariate and multivariate analysis of the variables potentially associated with the nasopharyngeal carriage of S. pneumoniae.
| Characteristics | Non–Carrier | Carrier | COR (95% CI) | AOR (95%CI) | |||
|---|---|---|---|---|---|---|---|
| Female | 84 (54.2) | 71 (45.8) | 1.16 (0.76–1.58) | 0.50 | |||
| Male | 119 (57.8) | 87 (42.2) | 1 | ||||
| 2–23 | 112 (58.3) | 80 (41.7) | 0.75 (0.44–1.28) | 0.29 | |||
| 24–41 | 52 (55.9) | 41 (44.1) | 0.83 (0.45–1.53) | 0.55 | |||
| 42–59 | 39 (51.3) | 37 (48.7) | 1 | ||||
| Rural | 39 (50.6) | 38 (49.4) | 1.33 (0.80–2.21) | ||||
| Urban | 164 (57.7) | 120 (42.3) | 1 | ||||
| Yes | 6 (37.5) | 10 (62.5) | 2.22 (0.80–6.24) | 0.13 | 2.12 (0.72–6.28) | 0.18 | |
| No | 197 (57.1) | 148 (42.9) | 1 | 1 | |||
| ≥5 | 98 (57.0) | 74 (43.0) | 0.94 (0.62–1.43) | 0.79 | |||
| <5 | 105 (55.6) | 84 (44.4) | 1 | ||||
| Yes | 136 (52.7) | 122 (47.3) | 1.61 (1.01–2.55) | 0.03 | 1.16 (0.66–2.03) | 0.61 | |
| No | 67 (65.0) | 36 (35.0) | 1 | 1 | |||
| Yes | 78 (47.6) | 86 (52.4) | 1.96 (1.28–2.98) | 0.002 | 1.80 (1.17–2.77) | 0.008 | |
| No | 125 (63.5) | 72 (36.5) | 1 | 1 | |||
| Yes | 113 (58.2) | 81 (41.8) | 0.82 (0.54–1.25) | 0.35 | |||
| No | 90 (53.9) | 77 (46.1) | 1 | ||||
| Yes | 166 (56.5) | 128 (43.5) | 0.95 (0.56–1.62) | 0.85 | |||
| No | 37 (55.2) | 30 (44.8) | 1 | ||||
| 1 | 50 (55.6) | 40 (44.4) | 1.04 (0.64–1.68) | 0.88 | |||
| ≥2 | 153 (56.5) | 118 (43.5) | 1 | ||||
| Fully * | 144 (57.8) | 105 (42.2) | 0.75 (0.46–1.22) | 0.24 | 1.07 (0.60–1.89) | 0.82 | |
| Partially ** | 15 (60.0) | 10 (40.0) | 0.68 (0.28–1.68) | 0.40 | 1.06 (0.40–2.83) | 0.90 | |
| None *** | 44 (50.6) | 43 (49.4) | 1 | 1 | |||
| Yes | 34 (41.5) | 48 (58.5) | 2.20 (1.33–3.63) | 0.002 | 2.07 (1.24–3.44) | 0.005 | |
| No | 169 (60.6) | 110 (39.4) | 1 | 1 | |||
| Yes | 42 (53.2) | 37 (46.8) | 1.17 (0.71–1.93) | 0.53 | |||
| No | 161 (57.1) | 121 (42.9) | 1 | ||||
| Yes | 8 (42.1) | 11 (57.9) | 1.82 (0.72–4.65) | 0.208 | 2.02 (0.77–5.30) | 0.15 | |
| No | 195 (57.0) | 147 (43.0) | 1 | 1 | |||
| Yes | 4 (33.3) | 8 (67.7) | 2.65 (0.78–8.98) | 0.12 | 3.15 (0.09–10.9) | 0.07 | |
| No | 199 (57.0) | 150 (43.0) | 1 | 1 |
* vaccinated with 3 doses; ** vaccinated with 1 or 2 doses; *** unvaccinated; COR: crude odd ratio; AOR: adjusted odds ratio; CI: 95% confidence interval.